Latest News

Date Title Topic
20 May 2015 Pembrolizumab Seems to be a New Immune Checkpoint Inhibitor Option for NSCLC, However is our Knowledge on Tumour Biomarkers Enough? Lung and other thoracic tumours
15 May 2015 Results of a study presented at the ESMO World Congress on Gastrointestinal Cancer 2014 and the ESMO Congress 2014 published in The New England Jour...
ESMO Election 2018-2019
08 May 2015 IMPAKT 2015 News: Molecular Screening of Patients with Metastatic Breast Cancer Can Be Carried-Out Across EU Countries Breast cancer - Personalised medicine
07 May 2015 IMPAKT 2015 News: Constitutively Activated STAT3 May Be a Predictive Marker for Resistance to Trastuzumab in Patients with HER2 Positive Breast Cancer Breast cancer - Translational research - Anticancer agents & Biologic therapy
07 May 2015 IMPAKT 2015 News: A Circulating Tumour Cell Liquid Biopsy May Be Used for Non-Invasive Mutational Analysis in Patients with Breast Cancer Breast cancer - Translational research
07 May 2015 IMPAKT 2015 News: PI3 Kinase and CDK4/6 Inhibitors Are Highly Active in ER-Positive Breast Cancer Breast cancer - Translational research - Anticancer agents & Biologic therapy
07 May 2015 IMPAKT 2015 News: Gene Expression Signatures May Signal Clinical Activity of Palbociclib in Patients with Breast Cancer Breast cancer - Translational research - Anticancer agents & Biologic therapy
05 May 2015 Survey: The role of precision medicine in “Real Life” management of breast cancer patients
24 Apr 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Nivolumab Melanoma - Immuno-oncology
Abstracts
21 Apr 2015 Phase III Randomised Trial Shows Pembrolizumab Superiority When Compared to Ipilimumab in Patients with Advanced Melanoma Melanoma - Immuno-oncology
17 Apr 2015 ELCC 2015 News: Circulating Tumour Cells May Be a Prognostic Marker for Disease Recurrence Following Radical Resection in Patients with NSCLC Translational research - Lung and other thoracic tumours
17 Apr 2015 ELCC 2015 Press Release: DNA Blood Test Detects Lung Cancer Mutations Translational research - Lung and other thoracic tumours
17 Apr 2015 ELCC 2015 Press Release: One in Four Advanced Lung Cancer Patients Tested for EGFR Mutations Started on First-line Treatment Before Test Results Available Bioethics, legal and economic issues - Lung and other thoracic tumours